Rhythm Biosciences Limited (RHY.AX)

AUD 0.08

(-3.53%)

Net Debt Summary of Rhythm Biosciences Limited

  • Rhythm Biosciences Limited's latest annual net debt in 2024 was -545.67 Thousand AUD , up 86.49% from previous year.
  • Rhythm Biosciences Limited's latest quarterly net debt in 2024 FY was -545.67 Thousand AUD , up 86.49% from previous quarter.
  • Rhythm Biosciences Limited reported annual net debt of -4.03 Million AUD in 2023, up 45.27% from previous year.
  • Rhythm Biosciences Limited reported annual net debt of -7.38 Million AUD in 2022, down -231.19% from previous year.
  • Rhythm Biosciences Limited reported quarterly net debt of -545.67 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.
  • Rhythm Biosciences Limited reported quarterly net debt of -545.67 Thousand AUD for 2024 FY, up 86.49% from previous quarter.

Annual Net Debt Chart of Rhythm Biosciences Limited (2024 - 2017)

Historical Annual Net Debt of Rhythm Biosciences Limited (2024 - 2017)

Year Net Debt Net Debt Growth
2024 -545.67 Thousand AUD 86.49%
2023 -4.03 Million AUD 45.27%
2022 -7.38 Million AUD -231.19%
2021 -2.22 Million AUD -26.94%
2020 -1.75 Million AUD 62.87%
2019 -4.72 Million AUD 39.23%
2018 -7.78 Million AUD -420.42%
2017 -1.49 Million AUD 0.0%

Peer Net Debt Comparison of Rhythm Biosciences Limited

Name Net Debt Net Debt Difference
Australian Clinical Labs Limited 282.76 Million AUD 100.193%
BCAL Diagnostics Limited -5.83 Million AUD 90.643%
Genetic Signatures Limited -35.03 Million AUD 98.442%
Genetic Technologies Limited -377.06 Thousand AUD -44.717%
Healius Limited 1.53 Billion AUD 100.035%
Imagion Biosystems Limited 5.81 Million AUD 109.39%
Integral Diagnostics Limited 315.35 Million AUD 100.173%
INOVIQ Ltd -8.69 Million AUD 93.727%
Microba Life Sciences Limited -20.49 Million AUD 97.337%
Monash IVF Group Limited 48.23 Million AUD 101.131%
Sonic Healthcare Limited 3.87 Billion AUD 100.014%